China Taxes Contraceptives to Boost Births

China has implemented a 13% value-added tax (VAT) on condoms and other contraceptives, effective January 1, 2026, ending a three-decade exemption. This policy reversal is a key part of China's broader strategy to combat its rapidly declining birth rate and address a looming demographic crisis, which has seen the population shrink for three consecutive years. Concurrently, China has exempted VAT on childcare, elder-care, disability, and marriage-related services to alleviate financial burdens on families. The move has sparked considerable debate on platforms like Weibo, with critics raising concerns about potential increases in unintended pregnancies and sexually transmitted diseases, given a documented rise in HIV/AIDS cases. Demographers like He Yafu and Qian Cai suggest the tax's direct impact on fertility rates may be limited, as the cost of raising a child in China remains among the highest globally, as highlighted by the YuWa Population Research Institute. The policy reflects China's pivot from its strict one-child policy era to actively encouraging larger families, but its effectiveness is questioned by experts and the public alike, who point to deeper structural issues like economic uncertainty and the unequal burden of childcare.